Selected article for: "active research area and acute disease"
Author: Li, Yue; Wang, Xingjian; Wang, Wei
Title: The Impact of COVID-19 on Cancer
  • Cord-id: 3ckbaafu
  • Document date: 2021_9_17
    • ID: 3ckbaafu
    Snippet: Since late December 2019, the 2019 coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its rapid international spread have posed a global health threat. The World Health Organization has declared the outbreak of COVID-19 as “public health emergency of international concern”. COVID-19 not only brings tremendous pressure to the medical system but also brings new challenges to the global economy. The occurrence and development of cancer has
    Document: Since late December 2019, the 2019 coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its rapid international spread have posed a global health threat. The World Health Organization has declared the outbreak of COVID-19 as “public health emergency of international concern”. COVID-19 not only brings tremendous pressure to the medical system but also brings new challenges to the global economy. The occurrence and development of cancer has always been an area of active research, and COVID-19 also has a long-lasting impact on the diagnosis, treatment, and research of cancer. In the context, we review the adverse effects of COVID-19 on the screening, diagnosis, treatment and prognosis of cancer patients and the countermeasures in this situation, and provide solutions for improving the quality of life of cancer patients in the normalized prevention and control of COVID-19.

    Search related documents:
    Co phrase search for related documents
    • acute kidney injury and long term problem: 1
    • acute kidney injury and lung adenocarcinoma: 1
    • acute lymphoblastic leukemia and adjuvant chemotherapy: 1
    • acute sars sars respiratory syndrome coronavirus and lung adenocarcinoma: 1
    • adjuvant chemotherapy and lung adenocarcinoma: 1, 2
    • liver cell and lung adenocarcinoma: 1, 2, 3, 4